Volume 20, Issue 5 (August 2022)
Nursing and Midwifery Journal 2022, 20(5): 370-378 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini F, Masudi N, Mohamadi E. CANCER PATIENTS' EXPERIENCE OF BARRIERS TO PARTICIPATION IN CHEMOTHERAPY: A QUALITATIVE CONTENT ANALYSIS. Nursing and Midwifery Journal 2022; 20 (5) :370-378
URL: http://unmf.umsu.ac.ir/article-1-4288-en.html
URL: http://unmf.umsu.ac.ir/article-1-4288-en.html
1- Assistant Professor, Faculty of Nursing and Midwifery, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2- Professor of Nursing, Department of Medical Surgical Nursing, School of Nursing and Midwifery, Trauma Nursing Research Center, Kashan University of Medical Sciences, Kashan, Iran (Corresponding Author) ,fati1317@gmail.com
3- Professor of Nursing, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Professor of Nursing, Department of Medical Surgical Nursing, School of Nursing and Midwifery, Trauma Nursing Research Center, Kashan University of Medical Sciences, Kashan, Iran (Corresponding Author) ,
3- Professor of Nursing, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Abstract: (1770 Views)
Background & Aims: Cancer is one of the main causes of death and disability in the world. One of the main ways to treat this disease is chemotherapy. Despite its importance, some patients neglect to do it. This study aimed to investigate the patient's experience of the obstacles to participating in chemotherapy.
Materials & Methods: The present study is a qualitative study that was conducted using in-depth and semi-structured interviews with 44 participants. The data were analyzed by conventional content analysis using MAXQDA version 10 software.
Results: By analyzing the findings, there are nine subcategories including 1- lack of support from the surrounding environment, 2- cultural and social bottlenecks in front of chemotherapy, 3- personal helplessness of the patient, 4- personal beliefs of the patient, 5- non-compliance with the conditions of the disease and treatment, 6- economic conditions of the patient, 7- non-availability of appropriate treatment facilities, 8- Poor professional skills of the treatment staff, and 9- bad outcome despite the treatment. These subclasses were finally formed into three main classes: 1- lack of support from the surrounding environment, 2- Obstacles related to the patient, and 3- Obstacles related to treatment.
Conclusion: The experience of patients showed that there are three main obstacles against chemotherapy. Dealing with some of these obstacles requires education to the patient and family, as well as micro and macro changes at the level of medical centers. Others require structural changes in the culture of the society and the policies of the Ministry of Health.
Materials & Methods: The present study is a qualitative study that was conducted using in-depth and semi-structured interviews with 44 participants. The data were analyzed by conventional content analysis using MAXQDA version 10 software.
Results: By analyzing the findings, there are nine subcategories including 1- lack of support from the surrounding environment, 2- cultural and social bottlenecks in front of chemotherapy, 3- personal helplessness of the patient, 4- personal beliefs of the patient, 5- non-compliance with the conditions of the disease and treatment, 6- economic conditions of the patient, 7- non-availability of appropriate treatment facilities, 8- Poor professional skills of the treatment staff, and 9- bad outcome despite the treatment. These subclasses were finally formed into three main classes: 1- lack of support from the surrounding environment, 2- Obstacles related to the patient, and 3- Obstacles related to treatment.
Conclusion: The experience of patients showed that there are three main obstacles against chemotherapy. Dealing with some of these obstacles requires education to the patient and family, as well as micro and macro changes at the level of medical centers. Others require structural changes in the culture of the society and the policies of the Ministry of Health.
Type of Study: Qualitative |
Subject:
پرستاری
References
1. Motlagh A, Ehsani-Chimeh E, Yarmali M, Moshiri F, Roshandel G, Partovipour E, Salavati F, Khoshabi M, Tavakoli N, Asgari F, Raisi A. Iran National Cancer Control Program (IrNCCP) in Practice. Sci J Kurdistan Univ Med Sci 2021;26(5):84-97. [DOI:10.52547/sjku.26.5.84]
2. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 2022;72(5):409-36. [DOI:10.3322/caac.21731] [PMID]
3. C Siegel RL, Miller KD, Jemal A. CA: a cancer journal for clinicians. Cancer Stat 2019;69:7-34. [DOI:10.3322/caac.21551] [PMID]
4. Hatta T, Narita K, Yanagihara K, Ishiguro H, Murayama T, Yokode M. Erratum to: Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT). BMC Med Inform Decis Mak 2016;16(1):28.
https://doi.org/10.1186/s12911-016-0260-0 [DOI:10.1186/s12911-016-0266-7]
5. Keliddar I, Tabar A, Torabipour M. Factors Affecting Community Health Volunteers' Motivation to Participate in Health Programs in Comprehensive Health Service Centers. J Qual Res Health Sci 2022;11:61-73. [Google Scholar]
6. Batra A, Marchioni M, Hashmi AZ, Lonergan PE, Morgans AK, Nead KT, et al. Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review. J Geriatr Oncol 2021;12(5):687-95. [DOI:10.1016/j.jgo.2020.11.002] [PMID]
7. Refaei M, Khakbazan Z, Dehghan Nayeri N. Regular Cervical Cancer Screening for Iranian Women: Facilitators and Barriers. J Qualit Res Health Sci 2020;9(2):155-65. [Google Scholar]
8. Luutonen S, Sintonen H, Stormi T, Salminen E. Health-related quality of life during adjuvant radiotherapy in breast cancer. Qual Life Res 2014;23(4):1363-9. [DOI:10.1007/s11136-013-0554-y] [PMID]
9. van der Linden SD, Gehring K, Rutten GJM, Kop WJ, Sitskoorn MM. Prevalence and correlates of fatigue in patients with meningioma before and after surgery. Neurooncol Pract 2020;7(1):77-85. [DOI:10.1093/nop/npz023] [PMID] [PMCID]
10. Lazenby M. Understanding and addressing the religious and spiritual needs of advanced cancer patients. Semin Oncol Nurs 2018;34(3):274-83. [DOI:10.1016/j.soncn.2018.06.008] [PMID]
11. Rezaii T, Hirschberg AL, Carlström K, Ernberg M. The influence of menstrual phases on pain modulation in healthy women. J Pain 2012;13(7):646-55. [DOI:10.1016/j.jpain.2012.04.002] [PMID]
12. Taher TMJ, Majed JM, Ahmed YF, Sarray FTR. The causes of non-compliance to treatment among type 2 diabetes mellitus patients. J Contemporary Stud Epidemiol Pub Health 2021;2(2):ep21006. [DOI:10.30935/jconseph/11276]
13. Sajjadi M, Mohammadpour A, Mahmoudi M. Correlation between Uncertainty in the illness, demographic and clinical factors with adherence to treatment in patients with cancer. J Sabzevar Univ Med Sci 2017;24(3):205-10. [URL]
14. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs 2008;62(1):107-15. [DOI:10.1111/j.1365-2648.2007.04569.x] [PMID]
15. Kyngäs H, Kääriäinen M, Elo S. The trustworthiness of content analysis. In: The Application of Content Analysis in Nursing Science Research. Cham: Springer International Publishing; 2020. p. 41-8. [DOI:10.1007/978-3-030-30199-6_5]
16. Vanaki Z, Yekta P, Kazemnejad Z, Heydarnia AN. Interpretation of support for cancer patients under chemotherapy: a qualitative research. Iran J Psychiatr Clin Psychol 2003;10(1):53-61. [Google Scholar]
17. 1. Bandura A, Evans RI. Albert Bandura. Insight Media; 2006. [DOI:10.1037/11571-002]
18. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998;317(7161):771-5. [DOI:10.1136/bmj.317.7161.771] [PMID] [PMCID]
19. Saravi FK, Navidian A, Tabas EE, Shad TS. Prediction of the quality of life in the adolescents with diabetes based on self-efficacy. Med Surg Nurs J 2016;5(3). [Google Scholar]
20. van Dijk EFMM, Coşkuntürk M, Zuur AT, van der Palen J, van der Graaf WTA, Timmer-Bonte JNH, et al. Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands. Neth J Med 2016;74(7):292-300. [Google Scholar]
21. Davari M, Moafi A, Yarmohammadian MH, Haghighi EK. The direct medical costs of acute lymphocytic leukemia (ALL) in children in Isfahan province. J Health Info Manag 2015;11(7):1047-57. [Google Scholar]
22. Bestvina CM, Zullig LL, Yousuf Zafar S. The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature. Future Oncol 2014;10(14):2189-99. [DOI:10.2217/fon.14.130] [PMID]
23. Fjose M, Eilertsen G, Kirkevold M, Grov EK. "Non-palliative care"-a qualitative study of older cancer patients' and their family members' experiences with the health care system. BMC Health Serv Res 2018;18(1):1-2. [DOI:10.1186/s12913-018-3548-1] [PMID] [PMCID]
24. Caliskan Yilmaz M, Ozsoy SA. Effectiveness of a discharge-planning program and home visits for meeting the physical care needs of children with cancer. Supp Care Cancer 2010;18(2):243-53. [DOI:10.1007/s00520-009-0650-2] [PMID]
25. Wu S, Chee D, Ugalde A, Butow P, Seymour J, Schofield P. Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study. Palliat Support Care 2015;13(2):255-63. [DOI:10.1017/S1478951513001260] [PMID]
26. 26. Ghoshal S, Miriyala R, Elangovan A, Rai B. Why newly diagnosed cancer patients require supportive care? An audit from a regional cancer center in India. Indian J Palliat Care 2016;22(3):326-30. [DOI:10.4103/0973-1075.185049] [PMID] [PMCID]
27. Esmaeili R, Ahmadi F, Mohammadi E, Tirgari Seraj A. Support: The major need of patients confronting with cancer diagnosis. J Mazandaran Univ Med Sci 2012;22(89):21-30. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Contact Information
Address: Urmia University of Medical Sciences, Deputy of Research and Technology,Djahad Ave.,
Urmia-5714783734, IRAN
P.O. Box: 1138,
Tel: 044 - 331937224
Fax: 044 - 32240642
E-Mail:
j.nur.mid
gmail.com, unmfumsu.ac.ir